ArticleJAMA internal medicine2015

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness.

Eric C T Geijteman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.